Bhavin Mehta's most recent trade in Kilitch Drugs(I) Ltd. was a Disposal of 841,046 Equity Shares done . Disclosure was reported to the exchange on Aug. 28, 2024 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
Bhavin Mehta's has made SAST transactions in Kilitch Drugs(I) Ltd. recently where a Acquisition of 841,046 shares done . Disclosure was reported to the exchange on Aug. 27, 2024.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kilitch DrugsI | Mira Bhavin Mehta | Promoter | Acquisition | 02 Sep 2024 | 841,046 | 841,046 (5.23%) | 5.23% | - | 23 Aug 2024 23 Aug 2024 |
SAST (29(1)) | - | Inter-se Transfer | |
| Kilitch DrugsI | Mira Bhavin Mehta | Promoter | Disposal | 02 Sep 2024 | 841,046 | 2,523,138 (15.69%) | 5.23% | - | 23 Aug 2024 23 Aug 2024 |
SAST (29(2)) | - | Inter-se Transfer | |
| Kilitch DrugsI | Bhavin Mukund Mehta | Promoter & Director | Disposal | 28 Aug 2024 | 841,046 | 2,523,138 (15.69%) | 5.23% | 0 | 0 | 23 Aug 2024 23 Aug 2024 |
Insider Trading | Equity Shares | Inter-se Transfer |
| Kilitch DrugsI | Mira Bhavin Mehta | Director | Acquisition | 28 Aug 2024 | 841,046 | 841,046 (5.23%) | 5.23% | 0 | 0 | 23 Aug 2024 23 Aug 2024 |
Insider Trading | Equity Shares | Inter-se Transfer |
| Kilitch DrugsI | Mira Bhavin Mehta | Promoter | Acquisition | 14 Aug 2024 | 841,046 | - | 5.23% | - | 23 Aug 2024 23 Aug 2024 |
SAST (10(5)) | - | None | |
| Global Defence Industries | Purvi Bhavin Mehta | Promoter | Disposal | 24 Jun 2022 | 17,800 | - | 7.42% | - | 17 Jun 2022 17 Jun 2022 |
SAST (29(2)) | - | Off Market | |
| Global Defence Industries | Bhavin Nitin Mehta | Promoter | Disposal | 24 Jun 2022 | 14,550 | - | 6.06% | - | 17 Jun 2022 17 Jun 2022 |
SAST (29(2)) | - | Off Market | |
| Kilitch DrugsI | Bhavin Mehta | Other | Acquisition | 27 Apr 2022 | 1,111,768 | - | 7.13% | - | 22 Apr 2022 22 Apr 2022 |
SAST (10(6)) | - | - | |
| Kilitch DrugsI | Bhavin Mukund Mehta | Director | Acquisition | 25 Apr 2022 | 1,111,768 | 3,114,184 (19.96%) | 7.13% | 0 | 0 | 22 Apr 2022 22 Apr 2022 |
Insider Trading | Equity Shares | Inter-se Transfer |
| Kilitch DrugsI | Bhavin Mukund Mehta | Promoter | Acquisition | 25 Apr 2022 | 1,111,768 | 3,114,184 (19.98%) | 7.13% | - | 22 Apr 2022 22 Apr 2022 |
SAST (29(1)) | - | Inter-se Transfer | |
| Kilitch DrugsI | Bhavin Mehta | Promoter | Acquisition | 12 Apr 2022 | 1,111,768 | - | 7.13% | - | 18 Apr 2022 18 Apr 2022 |
SAST (10(1)(a)) | - | None |